TH14128A - Peptides that control the blood - Google Patents
Peptides that control the bloodInfo
- Publication number
- TH14128A TH14128A TH9301000020A TH9301000020A TH14128A TH 14128 A TH14128 A TH 14128A TH 9301000020 A TH9301000020 A TH 9301000020A TH 9301000020 A TH9301000020 A TH 9301000020A TH 14128 A TH14128 A TH 14128A
- Authority
- TH
- Thailand
- Prior art keywords
- chemical formula
- compounds
- blood
- peptides
- control
- Prior art date
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 5
- 239000000126 substance Substances 0.000 claims abstract 5
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 claims 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 210000002798 bone marrow cell Anatomy 0.000 claims 1
- -1 broline Chemical compound 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000008929 regeneration Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 230000011132 hemopoiesis Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Abstract
การประดิษฐ์นี้ให้ได้สรประกบอของสูตรทั่วไปเป็น (สูตรเคมี)สารประกอบนี้มีแอคติวิดีควบคุมเลือดและสามารถ ใช้เพื่อ กระตุ้นการสร้างเม็ดเลือดแดง และสำหรับป้องกันและรักษาโรค ติดเชื้อไวรัส รา และแบคทีเรีย สิทธิบัตรยา This invention allows the creation of a common formula as (Chemical formula) This compound contains blood-regulating activity and can be used to stimulate red blood cell formation. And for the prevention and treatment of disease Infection with viruses, fungi and bacteria, patent drug
Claims (5)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH14128A true TH14128A (en) | 1994-06-22 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3686362D1 (en) | METHOD FOR TREATING GASTRIC DISEASES. | |
| ATE234919T1 (en) | ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF AFFAIRS IN WHICH THE EXPRESSION OF C-ERBB-2 PLAYS A ROLE | |
| MA26435A1 (en) | AMIDO-SUBSTITUTED BENZYLAMINE DERIVATIVES, THEIR PRECURSOR DERIVATIVES FOR MEDICAMENTS, THEIR PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND TREATMENT METHOD USING THE SAME. | |
| BG100293A (en) | 2,8-disubstituted quinazolinons | |
| LV10308A (en) | Ciliary neurotropic factor | |
| ATE91628T1 (en) | ACID-RESISTANT FIBROBLAST GROWTH FACTOR PREPARATION FOR THE TREATMENT OF GASTROINTESTINAL DISEASES. | |
| ATE439833T1 (en) | PHARMACEUTICAL PREPARATION CONTAINING A CATECHINE, ASCORBIC ACID, PROLINE AND LYSINE FOR THE TREATMENT OF NEOPLASTIC DISEASES | |
| ATE77751T1 (en) | MEANS FOR TREATMENT OF BONE DISEASES. | |
| ATE412666T1 (en) | COMPOSITIONS AND METHODS FOR MODULATING RSV INFECTIONS AND IMMUNITY | |
| ATE261737T1 (en) | PHARMACEUTICAL PREPARATIONS FOR TREATING DNA OF VIRAL INFECTIONS, WHICH CONTAIN A LOOP DIURETIC AND A CARDIAC GLYCOSIDE | |
| DE69929616D1 (en) | OXYHUMIC ACID AND ITS USE FOR THE TREATMENT OF DIFFERENT DISORDER | |
| IS5956A (en) | Use of bisphosphonic acid for the prevention and treatment of infection processes | |
| DE69522702D1 (en) | A STABLE AQUEOUS INFUSION SOLUTION CONTAINING A THROMBIN INHIBITOR | |
| TH14128A (en) | Peptides that control the blood | |
| ATE285773T1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
| DE3787437D1 (en) | SIALOSYL CHOLESTEROL, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM. | |
| DE19681032D2 (en) | Gene therapy nucleic acid construct, its production and use for the treatment of heart diseases | |
| DK82892D0 (en) | APPLICATION OF BRAIN ADDITION FROM BEES AND WHEPS FOR THE PREPARATION OF MEDICINAL PRODUCTS TO TREAT INFECTIONS | |
| ATE183204T1 (en) | AMINO SUGAR, GLYCOPROTEINS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THEIR USE | |
| DE60024969D1 (en) | 2-METHYL-3-BUTENYL-1-PYROPHOSPHORIC ACIDS AND MEANS FOR THE TREATMENT OF LYMPHOCYTES | |
| ATE126437T1 (en) | USE OF DEPOGEN TO TREAT RESTRICTED BLOOD CIRCULATION. | |
| DE69928814D1 (en) | USE OF TGF-BETA INHIBITORS FOR THE TREATMENT OF CEREBRAL DISEASES | |
| ATE135702T1 (en) | ARYL OR HETEROARYL-1-ALKYL-PYRROL-2-CARBOXYLIC ACID DERIVATIVES, FOR THE TREATMENT OF DISEASES CAUSED BY INTERLEUKIN-1 | |
| SU1655504A1 (en) | Method for treating endometritis in cows | |
| RU94020597A (en) | Method of pseudotuberculosis treatment |